Quick Answer
VitaNova Life Sciences Corp reported Gross Profit of $1.58 million for fiscal year 2025.
VitaNova Life Sciences Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $1.58M | +317.2% |
| 2024 | $377.7K | +894.0% |
| 2023 | $38.0K | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $316.3K | +67.1% | +21.3% |
| October 31, 2025 | $260.8K | +67.4% | +279.2% |
| July 31, 2025 | $68.8K | -6.0% | -63.7% |
| January 31, 2025 | $189.3K | +625.3% | +21.5% |
| October 31, 2024 | $155.8K | — | +113.0% |
| July 31, 2024 | $73.2K | — | +180.4% |
| January 31, 2024 | $26.1K | — | — |
| October 31, 2023 | $0.00 | — | — |
- VitaNova Life Sciences Corp showed an increase of +317.2% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from VitaNova Life Sciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: